CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Noncontrolling Interest, Change in Redemption Value
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Noncontrolling Interest, Change in Redemption Value of -$1.45 million for the 12-month period ending 2019-12-28, per its 10-K filed 2021-02-17.
Discontinued › Notes › Noncontrolling Interest
us-gaap:MinorityInterestChangeInRedemptionValue · last filed 2021-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for the quarter ending 2019-06-29 was -$1.87M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for the quarter ending 2019-03-30 was -$1.45M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for the quarter ending 2018-09-29 was -$1.11M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for the quarter ending 2014-12-27 was -$7.42M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for fiscal 2019 was -$1.45M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for fiscal 2018 was -$2.07M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for fiscal 2016 was $1.69M, a 823.50% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, change in redemption value for fiscal 2015 was $183.00K.
| Period end | Noncontrolling Interest, Change in Redemption Value 3 month | Noncontrolling Interest, Change in Redemption Value 6 month | Noncontrolling Interest, Change in Redemption Value 9 month | Noncontrolling Interest, Change in Redemption Value 12 month |
|---|---|---|---|---|
| 2019-12-28 | -$1.45M 10-K · filed 2021-02-17 | |||
| 2019-06-29 | -$1.87M 10-Q · filed 2019-11-06 | -$3.32M derived: sum of 2 quarters · filed 2020-10-29 | ||
| 2019-03-30 | -$1.45M 10-Q · filed 2020-10-29 | |||
| 2018-12-29 | -$2.07M 10-K · filed 2021-02-17 | |||
| 2018-09-29 | -$1.11M 10-Q · filed 2019-11-06 | |||
| 2016-12-31 | $1.69M 10-K · filed 2019-02-13 | |||
| 2015-12-26 | $183.00K 10-K · filed 2018-02-13 | |||
| 2014-12-27 | -$7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$7.42M derived: sum of 2 quarters · filed 2017-02-14 | -$7.42M derived: sum of 3 quarters · filed 2017-02-14 | -$7.42M 10-K · filed 2017-02-14 |
| 2014-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | |
| 2014-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2014-03-29 | $0.00 10-Q · filed 2014-04-30 | |||
| 2013-12-28 | -$10.56M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |